Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2014
08/06/2014CN102046651B 短螺旋体的新序列、免疫原性组合物、制备方法及其用途 Brachyspira new sequence, the immunogenic composition, preparation and use
08/06/2014CN102004152B 三聚氰胺胶体金检测卡及其生产和使用方法 Melamine colloidal gold test card and its production and use
08/06/2014CN101305017B 奶酪蛋白的酶水解产物中鉴定的生物活性肽及其生产方法 The method of producing biologically active peptides and enzymatic hydrolysates of proteins identified in cheese
08/05/2014US8798980 Molecular motor
08/05/2014US8796510 Polynucleotides and polypeptides in plants
08/05/2014US8796506 Transgenic sugar beet plants
08/05/2014US8796440 Promote system for regulatable gene expression in mammalian cells
08/05/2014US8796431 Efficient production of peptides
08/05/2014US8796430 Method to produce an immunoglobulin preparation with improved yield
08/05/2014US8796426 Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart
08/05/2014US8796421 Human epidermal growth factor receptor variant lacking an exon
08/05/2014US8796418 Stabilized alpha helical peptides and uses thereof
08/05/2014US8796417 Three-dimensional structure of functional material
08/05/2014US8796416 ACTH prophylactic treatment of renal disorders
08/05/2014US8796261 Bromodomain inhibitors and uses thereof
08/05/2014US8796237 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
08/05/2014US8796226 Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof
08/05/2014US8796223 Methods of inhibiting photoreceptor apoptosis
08/05/2014US8796220 Vaccine for the prevention of the recurrence HER2/neu expressing cancer
08/05/2014US8796219 Target-activated cell/tissue-penetrating peptide for delivery of impermeable compounds and use thereof
08/05/2014US8796216 Suppression of neuroendocrine diseases
08/05/2014US8796212 Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis
08/05/2014US8796207 Derivatisation of erythropoietin (EPO)
08/05/2014US8796206 Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administration
08/05/2014US8796205 Insulin derivative
08/05/2014US8796200 Optimized adhesin fragments and corresponding nanoparticles
08/05/2014US8796199 Uses of Cerberus and derivatives thereof
08/05/2014US8796026 Insecticidal proteins secreted from Bacillus thuringiensis and uses therefor
08/05/2014US8796004 Method for treating systemic DNA mutation disease
08/05/2014US8795999 Immunoadsorption of anti-von Willebrand factor cleaving protease antibodies
08/05/2014US8795996 Genes related to xylose fermentation and methods of using same for enhanced biofuel production
08/05/2014US8795985 FGF 21 polypeptides comprising two or more mutations and uses thereof
08/05/2014US8795959 Isolated glucokinase genomic polynucleotide fragments from chromosome 7
08/05/2014US8795690 Protective proteins of S. agalactiae, combinations thereof and methods of using the same
08/05/2014US8795685 Mutated HIV Nef for modulating immunity
08/05/2014US8795684 Agent for use in the topical or local treatment of cervical dysplasias
08/05/2014US8795676 Genes encoding major capsid protein L1 of human papilloma virus
08/05/2014US8795672 Compositions and methods for cancer immunotherapy
08/05/2014US8795670 Formulation of human antibodies for treating TNF-alpha associated disorders
08/05/2014US8795666 Antagonists of IL-23P19 for treatement of atopic dermatitis
08/05/2014US8795661 Molecules with extended half-lives, compositions and uses thereof
08/05/2014US8795627 Treatment of liver disorders by administration of RAP conjugates
08/05/2014US8795533 Chromatographic methods
08/05/2014CA2741641C Antibody specific for a mammaglobin polypeptide
08/05/2014CA2736972C Tumour-associated peptides that bind to mhc molecules
08/05/2014CA2649269C Protein complex and process for producing the same
08/05/2014CA2607150C Glucagon-like-peptide-2 (glp-2) analogues
08/05/2014CA2581840C Optimized vaccines to provide protection against ebola and other viruses
08/05/2014CA2557737C Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications
08/05/2014CA2552892C O-linked glycosylation of peptides
08/05/2014CA2486649C Fusion protein comprising angiopoietin receptor-binding and a multimerization domain
08/05/2014CA2466431C Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
08/05/2014CA2457140C Beta-amyloid-analogue - t-cell epitope vaccine
08/05/2014CA2430972C Fibrin fragments for treating inflammation
07/2014
07/31/2014WO2014117185A1 Rift valley fever virus glycoproteins, gn and gc, and their use
07/31/2014WO2014117155A1 Placenta growth factor in treating duchenne muscular dystrophy
07/31/2014WO2014117021A2 Methods, compositions, kits, and systems for selective enrichment of target cells
07/31/2014WO2014116753A1 N-terminal truncated insulin analogues
07/31/2014WO2014116706A1 Tissue plasminogen activator antibodies and methods of use thereof
07/31/2014WO2014116378A1 Use of proteins isolated from pseudomonas to control molluscs
07/31/2014WO2014116275A1 INHIBITION OF TISSUE FACTOR PATHWAY INHIBITOR WITH FACTOR Xa DERIVATIVES
07/31/2014WO2014115104A1 Influenza virus reassortment
07/31/2014WO2014114926A1 Glycoconjugate vaccines
07/31/2014WO2014114791A1 Method for antibody production
07/31/2014WO2014114787A1 Apolipoprotein a-i derived peptides for treatment of hyperglycaemia
07/31/2014WO2014083040A3 Progranulin as marker for autoimmune disorders
07/31/2014WO2014071266A3 Alteration of sex determination in flowering plants
07/31/2014WO2014041500A3 Double mutant coagulation factor viii and methods thereof
07/31/2014US20140215644 Soluble protein cd5 or cd6 for the treatment of cancer or tumor or for use as an adjuvant
07/31/2014US20140213776 Methods and compositions comprising human recombinant growth and differentiaton factor-5 (rhgdf-5)
07/31/2014US20140213769 Fusion protein for suppressing cancer cell growth and suppressing vasculogenesis, and anticancer composition comprising same
07/31/2014US20140213767 Haptens of paliperidone
07/31/2014US20140213766 Haptens of olanzipine
07/31/2014US20140213762 Casein hydrolysate
07/31/2014US20140213759 Process For Extraction Of Peptides And Its Application In Liquid Phase Peptide Synthesis
07/31/2014US20140213756 Liquid insulin compositions and methods of making the same
07/31/2014US20140213638 Compositions and Biomarkers for Heart Disease, Injury and Failure and Methods of Use
07/31/2014US20140213529 Pseudomonas exotoxin a with less immunogenic b cell epitopes
07/31/2014US20140213528 Fibrosuppressant Biotherapeutics
07/31/2014US20140213526 Small survival-promoting/immunomodulatory peptide for treatment of brain damage, neurodegenerative disorders, and inflammatory disorders
07/31/2014US20140213523 Biglycan variant polypeptides and methods of use
07/31/2014US20140213522 Pharmaceutical composition and method of preparing same
07/31/2014US20140213521 Oral Treatment of Inflammatory Bowel Disease
07/31/2014US20140213518 Methods of enhancing functioning of the large intestine
07/31/2014US20140213514 Insulin production methods and pro-insulin constructs
07/31/2014US20140213513 Exendin-4 Derivatives as dual GLP1/GIP or trigonal GLP1/GIP/Glucagon Agonists
07/31/2014US20140213511 Compositions and methods of use for treating metabolic disorders
07/31/2014US20140213510 Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
07/31/2014US20140213505 Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion
07/31/2014US20140213502 Chemical modification of apolipoprotein mimetic peptides for the production of therapeutic agents
07/31/2014US20140212969 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
07/31/2014US20140212952 Methods and compositions of human recombinant growth and differentiaton factor-5 (rhgdf-5) isolated from inclusion bodies
07/31/2014US20140212951 Expression conditions and methods of human recombinant growth and differentiaton factor-5 (rhgdf-5)
07/31/2014US20140212945 Rna targeting compounds and methods for making and using same
07/31/2014US20140212924 Human recombinant growth and differentiaton factor-5 (rhgdf-5)
07/31/2014US20140212897 Methods for predicting pregnancy outcome in a subject by hcg assay
07/31/2014US20140212888 T cell receptor and uses thereof
07/31/2014US20140212510 Capcna peptide therapeutics for cancer
07/31/2014US20140212481 Immunological methods and compositions for the treatment of alzheimer's disease
07/31/2014US20140212472 Methods of Treatment Using A Pentapeptide Derived From The C-Terminus Of Glucagon-Like Peptide 1 (GLP-1)
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 2916